BOSTON, April 6 (GenomeWeb News) - The era of pharmacogenomics has officially begun, according to Allan Roses, senior vice president of genetics research at GlaxoSmithKline, who showed examples of how his company is seeing clear benefits from the application of genomic tools in its discovery and development pipeline.
Registering provides access to this and other free content.
Already have an account?Login Now.
The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.
Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.
In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.
China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.